| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 266.349.868 $ | +124.758.645 $ | +268,7 % | 120.593.763 $ | +11.000.263 $ | +11,5 % | 109.593.500 $ | +15.838.168 $ | +21,9 % | |
| PFIZER INC | 49.792.410 $ | +19.608.515 $ | +65,0 % | 30.183.895 $ | +2.864.165 $ | +10,5 % | 27.319.730 $ | +2.423.525 $ | +9,7 % |
| BlackRock, Inc. | 46.582.273 $ | +22.366.113 $ | +92,4 % | 24.216.160 $ | +2.497.965 $ | +11,5 % | 21.718.195 $ | +1.494.133 $ | +7,4 % |
| TPG GP A, LLC | 45.667.787 $ | +20.026.448 $ | +78,1 % | 25.641.339 $ | +2.433.120 $ | +10,5 % | 23.208.219 $ | +2.058.793 $ | +9,7 % |
| STATE STREET CORP | 21.131.147 $ | +17.348.029 $ | +458,6 % | ||||||
| PRIMECAP MANAGEMENT CO/CA/ | 20.446.810 $ | +9.295.229 $ | +83,4 % | 11.151.581 $ | +2.373.239 $ | +27,0 % | 8.778.342 $ | +2.315.714 $ | +35,8 % |
| CITADEL ADVISORS LLC | 16.804.572 $ | +78.488 $ | +0,5 % | 16.726.084 $ | -657.175 $ | -3,8 % | 17.383.259 $ | +5.693.063 $ | +48,7 % |
| TWO SIGMA INVESTMENTS, LP | 13.116.113 $ | +8.425.999 $ | +179,7 % | ||||||
| VANGUARD GROUP INC | 12.674.704 $ | +1.488.949 $ | +13,3 % | 11.185.755 $ | +1.852.940 $ | +19,9 % | |||
| GEODE CAPITAL MANAGEMENT, LLC | 10.065.365 $ | +4.676.460 $ | +86,8 % | ||||||
| Frazier Life Sciences Management, L.P. | 9.263.870 $ | +3.963.682 $ | +74,8 % | ||||||
| Woodline Partners LP | 8.542.630 $ | +3.746.946 $ | +78,1 % | ||||||
| Patient Square Capital LP | 8.418.000 $ | +1.617.654 $ | +23,8 % | ||||||
| MARSHALL WACE, LLP | 8.413.082 $ | +8.021.864 $ | +2.050,5 % | ||||||
| MILLENNIUM MANAGEMENT LLC | 8.105.809 $ | +5.583.218 $ | +221,3 % | ||||||
| 266.349.868 $ | +124.758.645 $ | +268,7 % | 120.593.763 $ | +11.000.263 $ | +11,5 % | 109.593.500 $ | +15.838.168 $ | +21,9 % | |